Our Deals
Latest Deals
IPeople Acquired by RLDatix, a Portfolio Company of Five Arrows and TA Associates
Sengenics, a Portfolio Company of Summa Equity, Acquired by Standard BioTools
Actigraph, a Portfolio Company of Archimed, Acquired Biofourmis’ Life Science Business
Bio-Techne Divested Assets of Its Subsidiary, Atlanta Biologicals, to GeminiBio
BBI Solutions, a Portfolio Company of Novo Holdings, Acquired IBEX Technologies Inc. to Bolster Recombinant Protein Offering
Calyx has divested its 'Enterprise Technology' Division to Ennov, to Enhance Ennov’s portfolio of eClinical and eRegulatory Software Solutions
physIQ Acquired by Prolaio to Enhance its Next-Gen Connected Heart Care Technology for Clinical Care and Research
Grant Avenue Capital Recapitalizes CREO
QDx Pathology, a Portfolio Company of Hadley Capital, Acquired by LabGenomics to Expand Esoteric Testing Capabilities Globally
Catalyst Clinical Research, a Portfolio Company of QHP Capital, Acquired Genpro Research to Expand Global Footprint and Deepen Service Offerings
Versiti Acquired Quantigen to Further Expand Clinical Trial Expertise and Service Offering
Access Medical Labs Allies with Grupo Diagnostico Aries to Expand Diagnostic Lab Capabilities into North America
Clinical Site Services and Patient Advertising Guru Acquired by American Clinical Research Services to Add Tech-Enabled Patient Recruitment Capabilities
Grenova Completes Growth Recapitalization with Peloton Equity to Accelerate Strategic Objectives
PreventionGenetics acquired by Exact Sciences to Enable Earlier Cancer Detection and Hereditary Cancer Testing
Protocol First Joins Flatiron Health® to Help Bridge the Gap Between Real-World Care and Clinical Research
pharmasol Acquired by PharmaLex to Offer Turnkey End-to-End Pharmacovigilance Solutions
UpStream Completes $45 Million Funding Round Led by Dragoneer to Revolutionize Care for Older Adults
Intrinsic Clinical Systems and Pharmica Consulting Acquired by ProPharma Group to Provide Holistic Clinical Trial Execution Expertise